Evidence map›Paper›PMID 42153654›Full record

ArticlemBio2026

Structural basis of the AlgU-MucA

Tao Li, Yingzhi Wang, Ninglin Zhao, Chunlei Ge, Cuiling Wu, Ke Li, Li Li, Zhiqiang Wang, Ying Chen, Zhenpu Chen and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Tao Li *Cancer Biotherapy Center & Cancer Research Institute, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.ORCID 0000-0001-5930-2757
Yingzhi Wang *University-Town Hospital of Chongqing Medical University, Chongqing, China.
Ninglin Zhao *Center of Infectious Diseases, Division of Infectious Diseases in State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Chunlei GeCancer Biotherapy Center & Cancer Research Institute, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Cuiling WuCancer Biotherapy Center & Cancer Research Institute, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Ke LiCancer Biotherapy Center & Cancer Research Institute, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Li LiCancer Biotherapy Center & Cancer Research Institute, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Zhiqiang WangDepartment of Radiation Oncology, First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Ying ChenCancer Biotherapy Center & Cancer Research Institute, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Zhenpu ChenCancer Biotherapy Center & Cancer Research Institute, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Weike LiCancer Biotherapy Center & Cancer Research Institute, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Yang LiuCancer Biotherapy Center & Cancer Research Institute, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Zhonghui WangCancer Biotherapy Center & Cancer Research Institute, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Yun ShaCancer Biotherapy Center & Cancer Research Institute, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Hong YaoCancer Biotherapy Center & Cancer Research Institute, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Peking University Cancer Hospital Yunnan, Kunming, China.
Yibo ZhuCenter of Infectious Diseases, Division of Infectious Diseases in State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.ORCID 0000-0002-8014-6696
Rui BaoCenter of Infectious Diseases, Division of Infectious Diseases in State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China.ORCID 0000-0002-6083-8716

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In IMPORTANCE: Deletion of the

Indexed as

Bacterial ProteinsPseudomonas aeruginosaSigma FactorStress, PhysiologicalAlginatesGene Knockout TechniquesModels, MolecularProtein BindingProtein ConformationProteolysisAlginatesAlgU protein, Pseudomonas aeruginosaBacterial ProteinsSigma FactoralginateClpX/ClpP proteaseMucA-RIPPseudomonas aeruginosavirulence factors, SspB adaptorσ factor AlgU

Identifiers

PMID42153654
PMCPMC13251409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.